Patented Medicine Prices and R&D Spending in Canada, 2022 Annual Report

An annual report from the Patented Medicine Prices Review Board reviewing trends in the prices and sales of patented medicines in Canada. The report includes findings on pharmaceutical research and development spending and details the board's price review and reporting activities. It was last updated on the open_canada platform in April 2026.

Use Cases

• Analyze trends in patented medicine prices based on the annual review mentioned in the description
• Study sales patterns for patented drugs in Canada based on the report's focus
• Assess spending on pharmaceutical research and development in Canada based on the report's findings
• Review the regulatory activities of the PMPRB based on the updated information provided

Strengths

• Report is published by the official Patented Medicine Prices Review Board Canada.
• Data is licensed under the open OGL-CA-2.0 license.
• Last updated on 2026-04-16, indicating recent maintenance.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is presented in HTML format, which may require parsing for structured analysis.

Provenance

Source

Patented Medicine Prices Review Board Canada | Conseil d'examen du prix des médicaments brevetés Canada

Collection Method

Likely compiled from regulatory reporting and industry data.

Time Range

Covers the 2022 reporting year.

Freshness

Last updated 2026-04-16 19:26:55.673654; freshness should be verified.

Geography

Canada